Cathie Wood shells out $13.9 million for one high-stakes biotech stock
A fresh buy hints at where the ARK founder sees the next big biotech payoff.
Amid your entire noise over tariffs and rate-lower chatter, the perfect hotfoot is mostly to exercise traders who’ve performed it before.
What's Your Reaction?
